Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
CTXR Citius Pharmaceuticals, Inc. daily Stock Chart
CTXR [NASD]
Citius Pharmaceuticals, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-0.64 Insider Own39.08% Shs Outstand34.32M Perf Week-8.89%
Market Cap53.52M Forward P/E1.67 EPS next Y0.74 Insider Trans0.00% Shs Float32.88M Perf Month41.40%
Income-16.80M PEG- EPS next Q-0.11 Inst Own17.10% Short Float9.92% Perf Quarter89.23%
Sales- P/S- EPS this Y33.90% Inst Trans45.54% Short Ratio1.04 Perf Half Y31.12%
Book/sh0.65 P/B1.89 EPS next Y262.20% ROA-63.40% Target Price- Perf Year16.04%
Cash/sh0.10 P/C12.45 EPS next 5Y- ROE-75.80% 52W Range0.40 - 1.97 Perf YTD20.59%
Dividend- P/FCF- EPS past 5Y-6.20% ROI- 52W High-37.56% Beta1.79
Dividend %- Quick Ratio1.40 Sales past 5Y- Gross Margin- 52W Low207.50% ATR0.17
Employees1 Current Ratio1.40 Sales Q/Q- Oper. Margin- RSI (14)54.14 Volatility12.96% 15.81%
OptionableNo Debt/Eq0.01 EPS Q/Q34.40% Profit Margin- Rel Volume0.49 Prev Close1.34
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume3.13M Price1.23
Recom2.00 SMA2012.26% SMA5025.09% SMA20056.74% Volume1,548,563 Change-8.21%
Jul-14-20 08:47AM  
Citius Pharmaceuticals Brings on Myron S. Czuczman, M.D. as Chief Medical Officer (CMO) and Executive Vice President
PR Newswire
Jul-13-20 08:15AM  
Citius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
PR Newswire -8.21%
Jun-30-20 08:54AM  
Citius Pharmaceuticals (CTXR) Jumps: Stock Rises 5.1%
Zacks -22.07%
Jun-29-20 09:07AM  
Citius CEO Myron Holubiak to Appear on TD Ameritrade Network's The Watch List with Nicole Petallides
PR Newswire +5.07%
08:35AM  
Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing
GlobeNewswire
Jun-26-20 09:00AM  
Citius Receives FDA Response on Pre-Investigational New Drug (PIND) Application for its Induced Mesenchymal Stem Cells (iMSCs) to Treat Acute Respiratory Distress Syndrome (ARDS) in Patients with COVID-19
PR Newswire +27.78%
Jun-23-20 08:49AM  
Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020
GlobeNewswire
Jun-22-20 01:17PM  
Citius Pharmaceuticals to Deliver Virtual Presentation at the Life Sciences Investor Forum
PR Newswire
Jun-02-20 09:30AM  
Citius Receives Positive FDA Feedback on Its Submitted Plan to Study Catheter Compatibility for Mino-Lok® Therapy
PR Newswire
May-26-20 08:15AM  
Citius Announces Expanded Access Program for Investigational Phase 3 Mino-Lok®
PR Newswire
May-18-20 02:30PM  
Citius Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
PR Newswire
May-15-20 06:49AM  
Should You Be Concerned About Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Historical Volatility?
Simply Wall St.
May-14-20 09:00AM  
Citius Announces $7.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
PR Newswire -25.23%
May-13-20 08:15AM  
Citius Announces Data on NoveCite Mesenchymal Stem Cells (NC-MSCs) to be Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting
PR Newswire +5.71%
May-12-20 08:00AM  
Citius Pharmaceuticals Issues May 2020 Shareholder Letter
PR Newswire +9.38%
Apr-27-20 09:30AM  
Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) in COVID-19
PR Newswire +6.17%
Apr-01-20 08:07AM  
Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19
PR Newswire +36.64%
Mar-26-20 09:06AM  
Citius Pharmaceuticals Announces Publication in Antimicrobial Agents and Chemotherapy Journal of Positive Preclinical Results for Mino-Lok® in Rapidly Eradicating Candida Auris
PR Newswire +6.25%
Mar-18-20 09:46AM  
Citius Pharmaceuticals to Deliver Virtual Presentation at the Spring Investor Summit
PR Newswire -5.41%
Mar-16-20 06:22AM  
Here's Why We Worry About Citius Pharmaceuticals's (NASDAQ:CTXR) Cash Burn Situation
Simply Wall St. -7.41%
Mar-03-20 04:45PM  
Citius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City
ACCESSWIRE
Feb-26-20 08:00AM  
Citius Pharmaceuticals to Present at the 2020 LD Micro Virtual Conference
PR Newswire
Feb-25-20 08:00AM  
Citius Pharmaceuticals Cites Independent Estimates of Total Available World Market for Mino-Lok®
PR Newswire
Feb-10-20 08:28AM  
Citius Pharmaceuticals to Present at Noble Capital Markets' 16th Annual Investor Conference
PR Newswire
Feb-04-20 08:00AM  
Citius Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial
PR Newswire
Feb-03-20 08:00AM  
Citius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements
PR Newswire -6.78%
Jan-27-20 08:00AM  
Biotech Companies Think Big with Specialization - Fighting Deadly Bacteria and Viruses
Newsfile -9.60%
Dec-19-19 08:00AM  
Citius Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial
PR Newswire
Dec-04-19 08:00AM  
Citius Pharmaceuticals to Present at the 12th Annual LD Micro Main Event
PR Newswire
Nov-08-19 08:00AM  
Citius Pharmaceuticals Issues Corporate Update
PR Newswire
Oct-24-19 08:00AM  
Citius Pharmaceuticals to Present at the 5th Annual Dawson James Small Cap Growth Conference
PR Newswire -5.81%
Oct-15-19 08:00AM  
MicroCap Rodeo Investor Conference Lineup for October 15 and 16, 2019
ACCESSWIRE
08:00AM  
MicroCap Rodeo Investor Conference - Lineup for October 15 and 16, 2019
ACCESSWIRE
08:00AM  
Citius Pharmaceuticals to Present at the MicroCap Rodeo
PR Newswire
Oct-07-19 08:30AM  
Citius Reaches First Interim Analysis Milestone for Mino-Lok® Pivotal Trial
PR Newswire +6.15%
Oct-03-19 07:00AM  
Citius Provides Update on Activities From IDWeek 2019
PR Newswire
Sep-28-19 07:52AM  
Insider Buying: The Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Executive Chairman & Secretary Just Bought US$2.0m Worth Of Shares
Simply Wall St.
Sep-27-19 11:28AM  
Citius Announces Closing of $7.0 Million Underwritten Offering Priced At-the-Market
PR Newswire -5.57%
Sep-25-19 07:00AM  
Citius Announces Pricing of $7.0 Million Underwritten Offering Priced At-the-Market
PR Newswire
Sep-04-19 06:55AM  
Citius Announces Change To Primary Endpoint In Mino-Lok® Phase 3 Study
PR Newswire +7.62%
Aug-29-19 08:00AM  
Citius Pharmaceuticals, Inc. to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith.
PR Newswire
Jul-30-19 08:00AM  
Citius Provides Developmental Plans for Mino-Wrap
PR Newswire +6.98%
Jul-24-19 03:38PM  
Have Insiders Been Buying Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Shares?
Simply Wall St.
May-24-19 08:53AM  
Could Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Investor Composition Influence The Stock Price?
Simply Wall St.
May-13-19 08:47AM  
Citius Pharmaceuticals' Mino-Lok® Highly Efficacious in Rapidly Eradicating Candida auris
PR Newswire
May-01-19 08:00AM  
Citius Pharmaceuticals to Present at the ThinkEquity Conference
PR Newswire
Apr-30-19 09:45AM  
Citius Pharmaceuticals Presents Data on Mino-Lok® Showing 98% Clinical Efficacy
PR Newswire
Apr-23-19 08:30AM  
MicroCap Review Magazine Spring 2019 Issue Now Available
ACCESSWIRE
Apr-05-19 07:15PM  
Citius Pharmaceuticals Inc (CTXR) President and CEO Myron Z Holubiak Bought $200,648 of Shares
GuruFocus.com
Apr-04-19 08:30AM  
Citius Pharmaceuticals Successfully Raises $5.3 Million
PR Newswire -8.34%
Apr-01-19 09:00AM  
Citius Announces $5.3 Million Registered Direct Offering Priced At-the-Market
PR Newswire -6.34%
Mar-12-19 08:45AM  
LD Micro Virtual Conference Is Live, March 12th and 13th
ACCESSWIRE +8.15%
Mar-11-19 02:23PM  
Imagine Owning Citius Pharmaceuticals (NASDAQ:CTXR) And Taking A 97% Loss Square On The Chin
Simply Wall St. +8.00%
Feb-27-19 12:30PM  
Four Tech Stocks Looking To Test February Highs
ACCESSWIRE +5.51%
Jan-25-19 08:00AM  
Citius Pharmaceuticals to Present at NobleCon15 Investor Conference
PR Newswire
Jan-08-19 09:00AM  
Citius Licenses Mino-Wrap From MD Anderson Cancer Center
PR Newswire
Jan-04-19 10:45AM  
Citius Pharmaceuticals to Present at Biotech Showcase Investor Conference
PR Newswire
Dec-19-18 09:45AM  
Citius Pharmaceuticals Provides Updates on Mino-Lok® and CITI-002
PR Newswire
Dec-10-18 08:35AM  
Citius Pharmaceuticals Presentation Now Available for On-Demand Viewing
PR Newswire -5.22%
Dec-04-18 08:35AM  
Live Investor Conference & Webinar: NYSE, NASDAQ, and OTC companies present December 6th
PR Newswire
Nov-30-18 08:00AM  
Citius Pharmaceuticals to Present at the 11th Annual LD Micro Main Event
PR Newswire
Nov-29-18 04:35PM  
Citius Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com December 6
PR Newswire
Oct-25-18 08:00AM  
Citius Pharmaceuticals to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
PR Newswire
Oct-23-18 08:00AM  
Citius Reports On Activities During Infectious Disease Week 2018
PR Newswire
Sep-27-18 08:00AM  
Citius Announces The Publication Of European Patent For Mino-Lok®
PR Newswire
Sep-25-18 08:00AM  
Citius Announces The Issuance Of The Patent On The Advanced Stability Of Mino-Lok® By USPTO
PR Newswire
Aug-15-18 08:00AM  
Citius Pharmaceuticals Successfully Raises $10 Million
PR Newswire +24.81%
Aug-13-18 05:00PM  
Citius Announces Closing of $10.0 Million Underwritten Offering Priced At-the-Market
PR Newswire
Aug-09-18 01:55PM  
Pot Stocks & Biotech Stocks to Watch in 2018 & Beyond
ACCESSWIRE +48.25%
06:00AM  
Citius Announces Pricing of $10.0 Million Underwritten Offering Priced At-the-Market
PR Newswire
Jul-31-18 09:30AM  
CTRXs Ph3 Mino-Lok Fills Unmet Need for Catheter-Related Blood Infection Antibiotic
Zacks Small Cap Research -6.04%
Jul-24-18 08:00AM  
Citius Announces The Notice Of Allowance From The USPTO On The Advanced Stability Patent Application For Mino-Lok®
PR Newswire +8.09%
Jul-13-18 10:48AM  
Citius Announces Key Addition to its Scientific Advisory Board
PR Newswire +5.46%
Jul-09-18 08:00AM  
Citius Provides Clinical Update And Progress Of The Mino-Lok® Phase 3 Trial
PR Newswire
Jun-19-18 08:00AM  
Citius Announces United States Patent & Trademark Office Registered the Company's Mino-Lok® Trademark
PR Newswire
Mar-29-18 08:00AM  
Citius Announces $2.0 Million Registered Direct Offering Priced At-the-Market
PR Newswire
Mar-06-18 08:00AM  
Citius Reports Progress in Hemorroid Treatment Program
PR Newswire
Feb-15-18 08:00AM  
Citius Announces Enrollment Of First Patient In The Mino-Lok Phase 3 Trial
PR Newswire
Feb-13-18 08:00AM  
Citius Publishes Expert Roundtable Discussion On Treatment Considerations For Catheter Related Bacteremias
PR Newswire
Jan-31-18 08:00AM  
Citius Pharmaceuticals to Present at BIO CEO & Investor Conference
PR Newswire
Jan-04-18 08:00AM  
Citius Pharmaceuticals to Present at Biotech Showcase 2018
PR Newswire
Dec-18-17 08:00AM  
Citius Announces $6 Million Registered Direct Offering Priced At-the-Market
PR Newswire -5.11%
Dec-06-17 08:00AM  
Mino-Lok Phase 3 Clinical Trial Supplies Shipped to Sites
PR Newswire
Dec-04-17 01:36PM  
Citius Pharmaceuticals to Present at the 10th Annual LD Micro Invitational
PR Newswire
Nov-14-17 08:00AM  
Inserting And Removing Central Venous Catheters Cause Significant Discomfort In Cancer Patients And At Times Is Unnecessary
PR Newswire
Nov-07-17 08:00AM  
International Study at MD Anderson Sister Institutions Supports Mino Lok Phase 2b Results: Poster Presented at ID Week
PR Newswire +8.16%
Oct-31-17 07:15PM  
Is Citius Pharmaceuticals Incs (CTXR) Balance Sheet Strong Enough To Weather A Storm?
Simply Wall St. +5.92%
08:00AM  
Citius Pharmaceuticals, Inc. Receives "Fast Track" Designation By FDA For Mino-Lok Investigational Trial
PR Newswire
Oct-17-17 09:00AM  
Citius Pharmaceuticals to Present at the Dawson James 2017 Small Cap Growth Stock Conference
PR Newswire
Oct-11-17 09:00AM  
Citius Pharmaceuticals Issues Shareholder Letter
PR Newswire +5.31%
Sep-26-17 03:47PM  
Why Citius Pharmaceuticals Looks Undervalued
GuruFocus.com
Sep-05-17 07:00AM  
Citius Pharmaceuticals, Inc. Provides Phase 3 Update On Mino-Lok Clinical Trial Following FDA Meeting
PR Newswire
Aug-10-17 11:30AM  
Citius Pharmaceuticals, Inc. (Nasdaq: CTXR) to Ring The Nasdaq Stock Market Opening Bell
GlobeNewswire
Aug-08-17 11:25AM  
Citius Pharmaceuticals, Inc. Announces Closing of Public Offering
PR Newswire
Aug-03-17 09:31AM  
Citius Pharmaceuticals, Inc. Prices $6,800,000 Public Offering And Listing On The Nasdaq Capital Market
PR Newswire
Jun-13-17 10:37AM  
Citius Pharmaceuticals Presents At The 2017 Marcum MicroCap Conference
PR Newswire
Jun-08-17 05:00PM  
Citius Pharmaceuticals Announces Reverse Stock Split
PR Newswire
Jun-06-17 12:30PM  
Citius Pharmaceuticals to Present at the 7th Annual LD Micro Invitational
PR Newswire
Mar-23-17 07:00AM  
Citius Pharma Announces Addition of South America to World License
PR Newswire
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
open in yahoo | open in reuters | open in google